论文部分内容阅读
Amplification of the MYCN oncogene predicts treatment resistance in childhood neuroblastoma.We used a MYC target gene signature that predicts poor neuroblastoma prognosis to identify the histone chaperone FACT (facilitates chromatin transcription) as a crucial mediator of the MYC signal and a therapeutic target in the disease.